Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07479745
PHASE1
Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019
Sponsor: Grünenthal GmbH
View on ClinicalTrials.gov
Summary
The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019
Official title: An Open Label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019 in Healthy Male Participants
Key Details
Gender
MALE
Age Range
30 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-03-25
Completion Date
2026-06-06
Last Updated
2026-04-09
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
[14C]GRT6019
Single administration in a single dosing period.
Locations (1)
Quotient Sciences
Nottingham, United Kingdom